Tesamorelin
Visceral fat & GH
The visceral fat specialist — the only GHRH FDA approved for that purpose.
Research chemical vendors can't legally label products with the real name, so Tesamorelin often appears under coded SKUs. If you're shopping and see any of these, it's the same compound:
- Tesa
- Egrifta (Rx)
Codes shown are for identification only. Always verify third-party COAs before purchase.
A stabilized GHRH analog approved for HIV associated lipodystrophy. It selectively reduces visceral adipose tissue without affecting subcutaneous fat or causing the insulin issues of recombinant GH.
- Stubborn abdominal/visceral fat that diet and training can't move
- Improvements in lipid profile and liver fat
- Cognitive benefits in older adults (small clinical trials)
Educational only · Not a vendor claim
Stabilized GHRH analog — selectively reduces visceral adipose tissue via pituitary GH stimulation.
- Visceral fat reduction
- Improved lipid profile
- Liver fat reduction
- Cognitive support in older adults
- Waist circumference drop
- Improved labs
- Better sleep
- FDA approved for HIV lipodystrophy
- Only GHRH with visceral fat indication
- Strong clinical evidence
- Expensive
- Daily injection
- Joint stiffness possible
- Injection site reactions
- Joint discomfort
- Mild glucose elevation
Educational summary · Not medical advice · Discuss with a qualified clinician
Typical timeline
General pattern for the Muscle category. Individual response varies.
- Week 1Deeper sleep, vivid dreams, possible morning hand tingling — normal GH-axis signals.
- Weeks 2–4Recovery between sessions improves. Modest fullness in muscles from mild water retention.
- Weeks 4–8Body comp changes become visible. Fat drops slightly, muscle looks fuller. Bloodwork check recommended.
- Weeks 8+Cycle off for at least equal time to restore natural pulsatility. Track IGF-1 if running longer.
Pairs well with
Common combinations experienced users run alongside Tesamorelin. Always add one peptide at a time so you can attribute effects and side effects.
Read the safety guide before stacking.
The reconstitution math
- 1Reconstitute the 10 mg vial with 2 mL of bacteriostatic water. Tilt — don't shake.
- 2Concentration becomes 5,000 mcg/mL (5 mg/mL).
- 3For a 1 mg dose, draw 0.200 mL — that's 20 units on a 1 mL insulin syringe.
- 4One vial gives you approximately 10 doses.
Reminder: 100 units on an insulin syringe = 1 mL. Always start at half the listed dose for the first week and rotate injection sites between arms, legs, abdomen, and glutes.
Sign in to keep a private log of your doses and notes for Tesamorelin.
Use code ANYPEPTIDES15 for 15% off your order.
Discount may end or change without notice.